Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA
Biology and clinical impact of human natural killer cells.
Int J Hematol 2003 Jul;78(1):7-17
Farag SS, Fehniger TA, Becknell B, Blaser BW, Caligiuri MA
New directions in natural killer cell-based immunotherapy of human cancer.
Expert Opin Biol Ther 2003 Apr;3(2):237-50
Farag SS, Fehniger T, Ruggeri L, Velardi A, Caligiuri MA
Natural killer cells: biology and application in stem-cell transplantation.
Cytotherapy 2002;4(5):445-6
Shah MH, Baiocchi RA, Fehniger TA, Khatri VP, Gould M, Poiesz B, Bernstein ZP, Caligiuri MA
Cytokine replacement in patients with HIV-1 non-Hodgkin's lymphoma: the rationale for low-dose interleukin-2 therapy.
Cancer J Sci Am 2000 Feb;6 Suppl 1:S45-51
Fehniger TA, Carson WE, Caligiuri MA
Costimulation of human natural killer cells is required for interferon gamma production.
Transplant Proc 1999 May;31(3):1476-8
Book Chapters
Fehniger TA Chapter 31. Lymphoma.
In: The Washington Manual, Hematology and Oncology Subspecialty Consult, 2nd Edition (Cashen AF, Wildes T, eds), Lippincott, Williams, and Wilkins, Philadelphia, PA, 2008
Fehniger TA, Welch JS, Pluard TJ
Chapter 31. Hematologic Malignancies: Chronic Leukemias.
In: The Washington Manual of Oncology, 2nd Edition (Govindan R, ed), Lippincott, Williams, and Wilkins, Philadelphia, PA, 2007
Fehniger TA, Cooper MA, Caligiuri MA
Chapter 12. Murine cytokine models and the genesis of cancer.
In: Cytokines in the genesis and treatment of cancer (Caligiuri MA, Lotze MT, eds), Humana Press, Totowa, NJ, 2007